- Home
- MHK vs CORT Comparison
MHK vs CORT Comparison
Compare MHK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHK | CORT |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.6B |
| IPO Year | 1992 | N/A |
Fundamental Metrics
Financial Performance| Metric | MHK | CORT |
|---|---|---|
| Price | $109.13 | $82.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $135.92 | $130.20 |
| AVG Volume (30 Days) | ★ 916.8K | 852.0K |
| Earning Date | 02-05-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 6.71 | 0.87 |
| Revenue | ★ $10,722,900,000.00 | $741,172,000.00 |
| Revenue This Year | $0.30 | $23.79 |
| Revenue Next Year | $2.24 | $40.97 |
| P/E Ratio | ★ $16.27 | $94.20 |
| Revenue Growth | N/A | ★ 17.92 |
| 52 Week Low | $96.24 | $49.00 |
| 52 Week High | $143.13 | $117.33 |
Technical Indicators
Market Signals| Indicator | MHK | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 51.83 |
| Support Level | $108.23 | $78.07 |
| Resistance Level | $114.21 | $89.00 |
| Average True Range (ATR) | 3.06 | 3.47 |
| MACD | 0.04 | -0.29 |
| Stochastic Oscillator | 25.65 | 40.47 |
Price Performance
Historical ComparisonAbout MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.